Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-21-047542

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Banks Sonja Director 2021-12-08 Grant or award · Stock Option (right to buy) +30,000 30,000 D
Loading xslF345X03/doc4.xml…